The Role of SPARC in Procollagen Processing in the Periodontal Ligament

SPARC 在牙周膜原胶原加工中的作用

基本信息

项目摘要

DESCRIPTION (provided by applicant): The collagen fibers that span the periodontal ligament (PDL) connect teeth to the bone socket by weaving through the cementum of each tooth and into the alveolar bone. PDL has high rates of extracellular matrix turnover, as compared to other collagen rich tissues, characterized by procollagen synthesis, processing, and deposition in addition to uptake of insoluble collagen. Thus PDL provides an excellent tissue milieu for investigating mechanisms of procollagen processing. SPARC, a collagen-binding protein, has been identified as a key factor in collagen ECM deposition. Accordingly, we reported that SPARC-null mice had significantly less collagen in PDL as compared to age-matched wild type (WT) PDL. Interestingly, the PDL collagen fibers in SPARC-null mice were also significantly thinner than WT PDL fibers. When challenged with lipopolysaccharide to induce periodontal disease, SPARC-null mice had more severe disease as measured by loss of alveolar bone and PDL collagen. To address cellular mechanisms of decreased homeostatic collagen content and response to disease in the absence of SPARC, we cultured PDL fibroblasts and used a novel organ culture model. Our preliminary results demonstrated, both in vitro and ex vivo, that SPARC-null PDL fibroblasts had a deficiency in procollagen processing, as indicated by an accumulation of procollagen in null cells and tissue that was not evident in WT conditions. Furthermore, increases in procollagen were found associated with cell surfaces in the absence of SPARC. These results suggested that SPARC acts to decrease collagen interaction with cell surface receptors and that collagen engagement by cell surface receptors hampered efficient procollagen processing. These Specific Aims will test the hypothesis that SPARC mediates collagen homeostasis in PDL fibroblasts by competing with collagen receptor engagement, an activity required for efficient procollagen processing and subsequent collagen fibril incorporation. Mutant SPARC lacking collagen binding will be transfected into SPARC-null PDL fibroblasts to determine whether the collagen binding capacity of SPARC is required to modulate procollagen processing. In addition, adenovirus constructs will be used to knockdown two collagen cellular receptors known to share collagen binding sites with SPARC, integrin 2 and Discoidin Domain Receptor (DDR) 2, in both WT and SPARC-null PDL. We predict that knockdown of integrin 2 and DDR2 will promote procollagen processing in WT and SPARC-null PDL, thereby decreasing levels of procollagen and increasing levels of fully mature collagen 1. Furthermore, we will investigate the outcome of DDR2 and integrin 2 receptors knockdown on collagen fibril assembly using our ex vivo model. Thus, this project will determine the role of SPARC, DDR2, and integrin 2 on procollagen processing and collagen fibril formation. The training plan proposed here will test the above hypothesis and prepare me for a career as an academic scientist.
描述(由申请人提供):跨越牙周韧带(PDL)的胶原纤维通过每颗牙齿的牙骨质编织进入牙槽骨,将牙齿与骨窝连接起来。与其他富含胶原蛋白的组织相比,PDL具有较高的细胞外基质周转率,其特点是前胶原蛋白的合成、加工和沉积,以及不溶性胶原蛋白的吸收。因此,PDL为研究前胶原加工机制提供了良好的组织环境。SPARC是一种胶原结合蛋白,被认为是胶原ECM沉积的关键因子。因此,我们报道了SPARC-null小鼠与年龄匹配的野生型(WT) PDL相比,PDL中的胶原蛋白明显减少。有趣的是,SPARC-null小鼠的PDL胶原纤维也明显比WT的PDL纤维更薄。当用脂多糖诱导牙周病时,通过测量牙槽骨和PDL胶原蛋白的损失,SPARC-null小鼠的疾病更严重。为了研究在缺乏SPARC的情况下,稳态胶原含量下降和对疾病反应的细胞机制,我们培养了PDL成纤维细胞,并使用了一种新的器官培养模型。我们的初步结果表明,在体外和离体实验中,SPARC-null的PDL成纤维细胞在前胶原加工方面存在缺陷,正如在WT条件下不明显的前胶原在空细胞和组织中的积累所表明的那样。此外,在缺乏SPARC的情况下,前胶原蛋白的增加与细胞表面有关。这些结果表明,SPARC可以减少胶原与细胞表面受体的相互作用,并且胶原与细胞表面受体的结合阻碍了前胶原的有效加工。这些特定目标将验证SPARC通过与胶原受体参与竞争来介导PDL成纤维细胞胶原稳态的假设,胶原受体参与是有效的前胶原加工和随后的胶原原纤维结合所必需的活动。将缺乏胶原结合的突变型SPARC转染到SPARC缺失的PDL成纤维细胞中,以确定SPARC的胶原结合能力是否需要调节前胶原加工。此外,腺病毒构建体将用于敲除两种已知与SPARC共享胶原结合位点的胶原细胞受体,整合素2和盘状蛋白结构域受体(DDR) 2,在WT和SPARC-null PDL中。我们预测,整合素2和DDR2的敲低会促进WT和SPARC-null PDL的前胶原加工,从而降低前胶原水平,增加完全成熟胶原1的水平。此外,我们将使用离体模型研究DDR2和整合素2受体敲低对胶原原纤维组装的影响。因此,本项目将确定SPARC、DDR2和整合素2在前胶原加工和胶原纤维形成中的作用。这里提出的培养计划将检验上述假设,为我成为一名学术科学家做好准备。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jessica Marie Trombetta-eSilva其他文献

Jessica Marie Trombetta-eSilva的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jessica Marie Trombetta-eSilva', 18)}}的其他基金

The Role of SPARC in Procollagen Processing in the Periodontal Ligament
SPARC 在牙周膜原胶原加工中的作用
  • 批准号:
    8397173
  • 财政年份:
    2012
  • 资助金额:
    $ 4.85万
  • 项目类别:
The Role of SPARC in Procollagen Processing in the Periodontal Ligament
SPARC 在牙周膜原胶原加工中的作用
  • 批准号:
    9085189
  • 财政年份:
    2012
  • 资助金额:
    $ 4.85万
  • 项目类别:
The Role of SPARC in Procollagen Processing in the Periodontal Ligament
SPARC 在牙周膜原胶原加工中的作用
  • 批准号:
    8598808
  • 财政年份:
    2012
  • 资助金额:
    $ 4.85万
  • 项目类别:

相似海外基金

cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
cGAS-STING 通路靶向具有 CD46 趋向性和 AFP 启动子的复制腺病毒条件性复制限制用于治疗肝细胞癌
  • 批准号:
    10436626
  • 财政年份:
    2021
  • 资助金额:
    $ 4.85万
  • 项目类别:
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
  • 批准号:
    10557162
  • 财政年份:
    2021
  • 资助金额:
    $ 4.85万
  • 项目类别:
Molecular therapy of replication-competent adenoviruses targeting characteristic gene mutations found in mesothelioma
针对间皮瘤中发现的特征基因突变的具有复制能力的腺病毒的分子疗法
  • 批准号:
    21K08199
  • 财政年份:
    2021
  • 资助金额:
    $ 4.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
  • 批准号:
    10330464
  • 财政年份:
    2021
  • 资助金额:
    $ 4.85万
  • 项目类别:
Structural characterization of nucleoprotein cores of human adenoviruses
人腺病毒核蛋白核心的结构表征
  • 批准号:
    9807741
  • 财政年份:
    2019
  • 资助金额:
    $ 4.85万
  • 项目类别:
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
  • 批准号:
    41625-2013
  • 财政年份:
    2018
  • 资助金额:
    $ 4.85万
  • 项目类别:
    Discovery Grants Program - Individual
The therapeutic strategies with augmented replications of oncolytic adenoviruses for malignant mesothelioma
溶瘤腺病毒增强复制治疗恶性间皮瘤的治疗策略
  • 批准号:
    18K15937
  • 财政年份:
    2018
  • 资助金额:
    $ 4.85万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
  • 批准号:
    41625-2013
  • 财政年份:
    2017
  • 资助金额:
    $ 4.85万
  • 项目类别:
    Discovery Grants Program - Individual
Research on detection of novel adenoviruses by genetic methods
新型腺病毒的基因检测研究
  • 批准号:
    16K09118
  • 财政年份:
    2016
  • 资助金额:
    $ 4.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Exploring the effects of nutrient deprivation on T cells and oncolytic adenoviruses, in order to create immune activators for tumour therapy
探索营养剥夺对 T 细胞和溶瘤腺病毒的影响,以创造用于肿瘤治疗的免疫激活剂
  • 批准号:
    1813152
  • 财政年份:
    2016
  • 资助金额:
    $ 4.85万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了